Microvascular pathology in the aging human brain: Evidence that senile plaques are sites of microhaemorrhages

Neurobiology of Aging

Volumn 27, Issue 12, 2006, Pages 1786-1796

  Cullen, Karen M ^a,b   Kócsi, Zoltán ^c   Stone, Jonathan ^b  

^a Anatomy and Histology   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c Bendor Research Pty Ltd   (Australia)

Author keywords

Amyloid; Alzheimer's disease; Capillary; Collagen IV; Fibrinogen; Haem; Microhaemorrhage; Microvasculature; Senile plaques; von Willebrand factor

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; ANTIBODY; COLLAGEN TYPE 6; FERRIC FERROCYANIDE; FIBRINOGEN; HEME; VON WILLEBRAND FACTOR;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DOWN SYNDROME; FEMALE; HISTOCHEMISTRY; HUMAN; MALE; MICROANGIOPATHY; MICROVASCULATURE; PATHOGENESIS; PRIORITY JOURNAL; SENILE PLAQUE; TEMPORAL LOBE; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; CAPILLARY PERMEABILITY; FEMALE; HEME; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MICROCIRCULATION; MIDDLE AGED; PLAQUE, AMYLOID; SENILE PLAQUES;

EID: 33750000602     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.10.016     Document Type: Article

References (54)

1. Arriagada P.V., Growden J.H., Hedley-Whyte T., and Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42 (1992) 631-639
2. Atwood C.S., Bowen R.L., Smith M.A., and Perry G. Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply. Brain Res Rev 43 1 (2003) 164-178
3. Borroni B., Akkawi N., Martini G., Colciaghi F., Prometti P., Rozzini L., et al. Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci 203-204 (2002) 189-193
4. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82 (1991) 239-259
5. Brown W.R., Moody D.M., Thore C.R., and Challa V.R. Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis. Ann N Y Acad Sci 903 (2000) 39-45
6. Buee L., Hof P.R., Bouras C., Delacourte A., Perl D.P., Morrison J.H., et al. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (Berl) 87 5 (1994) 469-480
7. Busciglio J., Gabuzda D.H., Matsudaira P., and Yankner B.A. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 50 5 (1993) 2092-2096
8. Bush A.I., Martins R.N., Rumble B., Moir R., Fuller S., Milward E., et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 265 26 (1990) 15977-15983
9. Bussiere T., Gold G., Kovari E., Giannakopoulos P., Bouras C., Perl D.P., et al. Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience 117 3 (2003) 577-592
10. Chen M., Inestrosa N.C., Ross G.S., and Fernandez H.L. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun 213 1 (1995) 96-103
11. Chen X.H., Siman R., Iwata A., Meaney D.F., Trojanowski J.Q., and Smith D.H. Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am J Pathol 165 2 (2004) 357-371
12. Coria F., and Rubio I. Cerebral amyloid angiopathies. Neuropathol Appl Neurobiol 22 (1996) 216-227
13. Cullen K.M. Perivascular astrocytes within Alzheimer's disease plaques. Neuroreport 8 (1997) 1961-1966
14. Cullen K.M., and Halliday G.M. Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology. Neurobiol Aging 19 (1998) 297-306
15. Cullen K.M., Kócsi Z., and Stone J. Vascular relationships of haem-rich deposits in the aging cerebral cortex. J Cereb Blood Flow Metab 25 12 (2005) 1656-1667
16. D'Andrea M.R., Cole G.M., and Ard M.D. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging 25 5 (2004) 675-683
17. de la Torre J. Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann N Y Acad Sci 924 (2000) 136-152
18. De Meyer G., De Cleen D., Cooper S., Knaapen M., Jans D., Martinet W., et al. Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ Res 90 11 (2002) 1197-1204
19. Duyckaerts C., Bennecib M., Grignon Y., Uchihara T., He Y., Piette F., et al. Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol Aging 18 3 (1997) 267-273
20. Farkas E., De Vos R.A., Jansen Steur E.N., and Luiten P.G. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related?. Neurobiol Aging 21 2 (2000) 235-243
21. Ferrer I., Boada Rovira M., Sanchez Guerra M.L., Rey M.J., and Costa-Jussa F. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol 14 1 (2004) 11-20
22. Frackowiak J., Mazur-Kolecka B., Wisniewski H.M., Potempska A., Carroll R.T., Emmerling M.R., et al. Secretion and accumulation of Alzheimer's beta-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res 676 1 (1995) 225-230
23. Gearing M., Mirra S.S., Hedreen J.C., Sumi S.M., Hansen L.A., and Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 45 3 (1995) 461-466
24. Giannakopoulos P., Herrmann F.R., Bussiere T., Bouras C., Kovari E., Perl D.P., et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60 9 (2003) 1495-1500
25. Halliday G.M., McCann H.L., Pamphlett R., Brooks W.S., Creasy H., McCusker E., et al. Brainstem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation. Acta Neuropathol (Berl) 84 (1992) 638-650
26. Jellinger K.A. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109 5-6 (2002) 813-836
27. Jellinger K.A. The pathology of ischemic-vascular dementia: an update. J Neurol Sci 203-204 (2002) 153-157
28. Kalaria R.N., and Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6 3 (1995) 477-480
29. Kato T., Hirano A., Katagiri T., Sasaki H., and Yamada S. Neurofibrillary tangle formation in the nucleus basalis of Meynert ipsilateral to a massive cerebral infarct. Ann Neurol 23 (1988) 620-623
30. Kawai M., Kalaria R.N., Harik S.I., and Perry G. The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 137 6 (1990) 1435-1446
31. Koeppen A.H. The history of iron in the brain. J Neurol Sci 134S (1995) 1-9
32. Kudo T., Imaizumi K., Tanimukai H., Katayama T., Sato N., Nakamura Y., et al. Are cerebrovascular factors involved in Alzheimer's disease?. Neurobiol Aging 21 2 (2000) 215-224
33. Lang I.M., Moser K.M., and Schleef R.R. Expression of Kunitz Protease Inhibitor containing forms of amyloid fl{ligature}-protein precursor within vascular thrombi. Circulation 94 11 (1996) 2728-2734
34. Mari D., Parnetti L., Coppola R., Bottasso B., Reboldi G., Senin U., et al. Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease. Thromb Haemost 75 2 (1996) 216-218
35. Mayeux R., Tang M.X., Jacobs D.M., Manly J., Bell K., Merchant C., et al. Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Ann Neurol 46 3 (1999) 412-416
36. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 4 (1991) 479-486
37. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 9 (1989) 1159-1165
38. Nagele R.G., Wegiel J., Venkataraman V., Imaki H., and Wang K.C. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 25 5 (2004) 663-674
39. Pfeifer M., Boncristiano S., Bondolfi L., Stalder A., Deller T., Staufenbiel M., et al. Cerebral hemorrhage after passive anti-A-beta immunotherapy. Science 298 (2002) 1379
40. Racke M.M., Boone L.I., Hepburn D.L., Parsadainian M., Bryan M.T., Ness D.K., et al. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid. J Neurosci 25 (2005) 629-636
41. Regan R.F., and Rogers B. Delayed treatment of hemoglobin neurotoxicity. J Neurotrauma 20 1 (2003) 111-120
42. Reinhard Jr. J.F., Liebmann J.E., Schlosberg A.J., and Moskowitz M.A. Serotonin neurons project to small blood vessels in the brain. Science 206 4414 (1979) 85-87
43. Sato A., Sato Y., and Uchida S. Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain. Int J Dev Neurosci 19 3 (2001) 327-337
44. Schönheit B., Zarski R., and Ohm T.G. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25 6 (2004) 697-711
45. Shi J., Perry G., Smith M.A., and Friedland R.P. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 21 2 (2000) 357-361
46. Snowdon D.A. Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 37 2 (1997) 150-156
47. Su G.C., Arendash G.W., Kalaria R.N., Bjugstad K.B., and Mullan M. Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Res 818 (1999) 105-117
48. Szekely C.A., Thorne J.E., Zandi P.P., Ek M., Messias E., Breitner J.C., et al. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23 4 (2004) 159-169
49. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., et al. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161 5 (2002) 1869-1879
50. Thomas T., Thomas G., McLendon C., Sutton T., and Mullan M. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380 (1996) 168-171
51. van Dijk E.J., Prins N.D., Vermeer S.E., Koudstaal P.J., and Breteler M.M. Frequency of white matter lesions and silent lacunar infarcts. J Neural Transm Suppl 62 (2002) 25-39
52. Wagner K., Sharp F., Ardizzone T., Lu A., and Clark J. Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 23 6 (2003) 629-652
53. Wegiel J., Wisniewski H.M., Muzylak M., Tarnawski M., Badmajew E., Nowakowski J., et al. Fibrillar amyloid-beta production, accumulation, and recycling in transgenic mice pancreatic acinar cells and macrophages. Amyloid 7 2 (2000) 95-104
54. Wisniewski H.M., Wegiel J., Vorbrodt A.W., Mazur-Kolecka B., and Frackowiak J. Role of perivascular cells and myocytes in vascular amyloidosis. Ann N Y Acad Sci 903 (2000) 6-18